Sarcoidosis and immunoglobulin lambda II light-chain amyloidosis diagnosed after orthotopic heart transplantation: A case report and review of the literature

Modern Pathology

Volumn 18, Issue 3, 2005, Pages 451-455

  Treaba, Diana O ^a,c   Benson, Merrill D ^b   Assad, Lina W ^a   Dainauskas, John R ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PHENOPATH LABORATORIES   (United States)

Author keywords

Amyloidosis; Lambda light chain; Sarcoid granulomas

Indexed keywords

IMMUNOGLOBULIN LAMBDA CHAIN;

ACUTE KIDNEY FAILURE; ADULT; AFRICAN AMERICAN; AMYLOIDOSIS; AORTA; ASPIRATION PNEUMONIA; BLADDER; BONE MARROW; CARDIOMYOPATHY; CASE REPORT; DISEASE ASSOCIATION; FIBROSING ALVEOLITIS; HEART ATRIUM; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; KIDNEY; LARGE INTESTINE; LIVER; LUNG; LYMPH NODE; MALE; PARATHYROID GLAND; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SPLEEN; STOMACH; THYROID GLAND;

AMINO ACID SEQUENCE; AMYLOID; AMYLOIDOSIS; FATAL OUTCOME; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SARCOIDOSIS; SEQUENCE ANALYSIS, PROTEIN;

EID: 15444369900     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800277     Document Type: Review

References (24)

1. Salazar A, Pinto X, Mana J. Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders. Eur J Clin Invest 2001;31:1070-1077.
2. Hagemann GJ, Wurm K. The clinical, electrocardiographic and pathololgic features of cardiac sarcoidosis. In: Jones WW, Davies BD (eds). Sarcoidosis and Other Granulomatous Diseases, 8th International Conference. Alpha Omega: Cardiff, 1980, p 601.
3. Matsui Y, Iwai K, Tachicana T, et al. Clinico-pathological study on a fatal myocardial sarcoidosis. Ann NY Acad Sci 1976;278:445-469.
4. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138(Part 1): 299-302.
5. Stather D, Ford S, Kisilevsky R. Sarcoid, amyloid and acute myocardial failure. Mod Pathol 1998;11: 901-904.
6. Rakhit RD, Cleshman GJ, Cleland JGF. Sarcoid, amyloid and heart failure. Int J Cardiol 1993;41:180-182.
7. Churukian CJ. Improved Puchtler's Congo red method for demonstrating amyloid. J Histotechnol 2000;23: 139-141.
8. Lynch III JP, Sharma OP, Baughman RP. Extrapulmonary sarcoidosis. Semin Respir Infect 1998;13: 229-254.
9. Felker GM, Weimin Hu, Hare J, et al. The spectrum of dilated cardiomyopathy: The Johns Hopkins Experience with 1,278 patients. Medicine 1999;78: 270-283.
10. Mitchell DN, du Bois RM, Oldershaw PJ. Cardiac sarcoidosis: a potentially fatal condition that needs expert assessment. BMJ 1997;314:320-321.
11. Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in Japanese patients with highdegree atrioventricular block. Am Heart J 1997;134: 362-366.
12. Fleming HA. Death from sarcoid heart disease. United Kingdom series 1971-1986. 300 cases with 138 deaths. In: Grassi CG, Pozzi E (eds). Sarcoidosis and Other Granulomatous Disorders, 11th World Congress. Elsevier: Amsterdam, 1998, p 19.
13. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1977;63:86.
14. Donsky AS, Escobar J, Capehart J, et al. Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol 2002;89:1447-1449.
15. Martinetti M, Tinelli C, Kolek V, et al. 'The sarcoidosis map': a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995;152:557-564.
16. Kunikane H, Abe S, Yamaguchi E, et al. Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis. Thorax 1994;49:573-576.
17. Hamidi AK, Liepnieks JJ, Nakamura M, et al. A novel apolipoprotein A-I variant Arg 173Pro, associated with cardiac and cutaneous amyloidosis. Biochem Biophys Res Commun 1999;257:584-588.
18. Berlin M, Fodgell-Hahn A, Olerup O, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997;156:1601-1605.
19. Gilmore JD, Hawkins PN, Pepys MB. Amyloidosis: a review of recent diagnostic and therapeutic developments. Br J Hematol 1997;99:245-256.
20. Roberts WC, Bruce WF. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 1983;52:137-146.
21. Dunphy HC, Panella MJ, Grosso EL. Low grade B-cell lymphoma and concomitant extensive sarcoid like granulomas. A case report and review of the literature. Arch Pathol Lab Med 2000;124:152-156.
22. Brinker H. The sarcoidosis-lymphoma syndrome. Br J Cancer 1986;54:467-473.
23. Gertz MA, Kyle RA. Secondary systemic amyloidosis; response and survival in 64 patients. Medicine 1991; 70:246-256.
24. Hosenpud JD, DeMarco T, Frazier OH, et al. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation 1991;84(5 Suppl):338-343.